AU764660B2 - Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane - Google Patents

Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane

Info

Publication number
AU764660B2
AU764660B2 AU25337/00A AU2533700A AU764660B2 AU 764660 B2 AU764660 B2 AU 764660B2 AU 25337/00 A AU25337/00 A AU 25337/00A AU 2533700 A AU2533700 A AU 2533700A AU 764660 B2 AU764660 B2 AU 764660B2
Authority
AU
Australia
Prior art keywords
dna
nls
nuclear
transport
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU25337/00A
Other languages
English (en)
Other versions
AU2533700A (en
Inventor
Rainer Christine
Gregor Siebenkotten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza Cologne GmbH
Original Assignee
Amaxa AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19933939A external-priority patent/DE19933939A1/de
Application filed by Amaxa AG filed Critical Amaxa AG
Publication of AU2533700A publication Critical patent/AU2533700A/en
Application granted granted Critical
Publication of AU764660B2 publication Critical patent/AU764660B2/en
Assigned to AMAXA AG reassignment AMAXA AG Request to Amend Deed and Register Assignors: AMAXA GMBH
Assigned to LONZA COLOGNE AG reassignment LONZA COLOGNE AG Request to Amend Deed and Register Assignors: AMAXA AG
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Transplantation (AREA)
  • Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AU25337/00A 1999-01-08 2000-01-03 Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane Ceased AU764660B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19900513 1999-01-08
DE19900513 1999-01-08
DE19933939 1999-07-20
DE19933939A DE19933939A1 (de) 1999-01-08 1999-07-20 Ausnutzung zelleigener Transportsysteme zum Transfer von Nukleinsäuren durch die Kernhülle
PCT/DE2000/000061 WO2000040742A1 (de) 1999-01-08 2000-01-03 Ausnutzung zelleigener transportsysteme zum transfer von nukleinsäuren durch die kernhülle

Publications (2)

Publication Number Publication Date
AU2533700A AU2533700A (en) 2000-07-24
AU764660B2 true AU764660B2 (en) 2003-08-28

Family

ID=26051245

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25337/00A Ceased AU764660B2 (en) 1999-01-08 2000-01-03 Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane

Country Status (8)

Country Link
US (1) US6521456B1 (enExample)
EP (1) EP1141364A1 (enExample)
JP (2) JP3997056B2 (enExample)
CN (1) CN1262668C (enExample)
AU (1) AU764660B2 (enExample)
CA (1) CA2358040C (enExample)
IL (1) IL143983A0 (enExample)
WO (1) WO2000040742A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030069173A1 (en) * 1998-03-16 2003-04-10 Life Technologies, Inc. Peptide-enhanced transfections
AU764660B2 (en) * 1999-01-08 2003-08-28 Lonza Cologne Ag Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane
JP2003514564A (ja) * 1999-11-24 2003-04-22 エムシーエス マイクロ キャリア システムズ ゲーエムベーハー 核局在化シグナルまたはタンパク質導入領域の多量体を含むポリペプチド、および分子を細胞内へ移入するためのその使用法
EP1335933A2 (en) * 2000-11-24 2003-08-20 Pantheco A/S Pna analogues
AU2002216946A1 (en) * 2001-01-05 2002-07-16 Pantheco A/S Modified pna molecules
KR100912741B1 (ko) 2001-01-10 2009-08-18 아막사 아게 모듈식 트랜스펙션 시스템
WO2003092735A2 (en) * 2002-05-01 2003-11-13 Pantheco A/S Peptide nucleic acid conjugates with beta-amino acid polymers or reptoids
AU2003219576A1 (en) * 2003-04-03 2004-10-25 Korea Advanced Institute Of Science And Technology Conjugate for gene transfer comprising oligonucleotide and hydrophilic polymer, polyelectrolyte complex micelles formed from the conjugate, and methods for preparation thereof
US8969543B2 (en) * 2003-04-03 2015-03-03 Bioneer Corporation SiRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof
US20070149496A1 (en) * 2003-10-31 2007-06-28 Jack Tuszynski Water-soluble compound
CN101287835A (zh) * 2005-08-17 2008-10-15 株式会社百奥尼 用于siRNA细胞内输送的siRNA-亲水性聚合物结合物及其方法
EP1900820A1 (en) * 2006-09-13 2008-03-19 Amaxa AG Nuclear transport agent and method for producing said agent
WO2019219721A1 (en) 2018-05-18 2019-11-21 F. Hoffmann-La Roche Ag Targeted intracellular delivery of large nucleic acids

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5539082A (en) 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
AU682308C (en) 1992-04-03 2006-08-17 Regents Of The University Of California, The Self-assembling polynucleotide delivery system
US5574142A (en) 1992-12-15 1996-11-12 Microprobe Corporation Peptide linkers for improved oligonucleotide delivery
US5631237A (en) 1992-12-22 1997-05-20 Dzau; Victor J. Method for producing in vivo delivery of therapeutic agents via liposomes
JPH10501681A (ja) * 1994-02-22 1998-02-17 ダナ−ファーバー キャンサー インスティチュート 核酸送達システムならびにその合成および使用方法
JPH10501963A (ja) * 1994-04-15 1998-02-24 ターゲテッド ジェネティクス コーポレイション 遺伝子送達融合タンパク質
US5670347A (en) * 1994-05-11 1997-09-23 Amba Biosciences Llc Peptide-mediated gene transfer
WO1996040961A1 (en) * 1995-06-07 1996-12-19 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
DE19541679A1 (de) 1995-11-08 1997-05-15 Gerhard Dr Friedrich Nicht virale Gentransfersysteme mit NLS (nuclear localization sequences) und/oder magnetisierbaren Mikropartikeln und das damit verbundene Herstellungsverfahren
AUPN741696A0 (en) * 1996-01-05 1996-01-25 Commonwealth Scientific And Industrial Research Organisation Delivery of nucleic acids ii
WO1998028417A1 (en) * 1996-12-23 1998-07-02 Gene-Cell Nucleic acid constructs and uses thereof for direct nucleic acid incorporation into cells
AU7127598A (en) * 1997-04-18 1998-11-13 Millennium Pharmaceuticals, Inc. Novel molecules of the fthma-070-related protein family and the t85-related pro tein family and uses thereof
AU764660B2 (en) * 1999-01-08 2003-08-28 Lonza Cologne Ag Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane
US6312956B1 (en) * 1999-10-01 2001-11-06 Vanderbilt University Nuclear targeted peptide nucleic acid oligomer

Also Published As

Publication number Publication date
JP2002534437A (ja) 2002-10-15
CN1262668C (zh) 2006-07-05
JP3997056B2 (ja) 2007-10-24
CN1339068A (zh) 2002-03-06
US6521456B1 (en) 2003-02-18
EP1141364A1 (de) 2001-10-10
WO2000040742A1 (de) 2000-07-13
CA2358040C (en) 2008-06-10
CA2358040A1 (en) 2000-07-13
IL143983A0 (en) 2002-04-21
JP2006345867A (ja) 2006-12-28
AU2533700A (en) 2000-07-24

Similar Documents

Publication Publication Date Title
CA2358040C (en) Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane
US20120171770A1 (en) Bioengineered silk protein-based nucleic acid delivery systems
US20080199529A1 (en) Nanoparticle delivery vehicle
US6720310B1 (en) Transfer method for specific cellular localization of nucleic acids
JP2001503385A (ja) ポリヌクレオチド送達のための組成物および方法
CA2143308A1 (en) Translocation signal facilitated nuclear delivery of macromolecules
US6740524B1 (en) Nucleic acid transfer phage
IL284878B1 (en) Trem compositions and uses thereof
EP1098987B1 (en) Method for transformation of animal cells
JP2002539839A (ja) 転位ポリペプチドによる機能性タンパク質配列の送達
JP2002525066A5 (enExample)
AU2014267044A1 (en) Bacteriophage
CA2390104C (en) Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins
Min et al. Gene delivery using a derivative of the protein transduction domain peptide, K-Antp
JP2002533088A (ja) 非病原性トランスフェクションベクター
JP2022528325A (ja) 増強型トランスフェクション
KR20020013488A (ko) 핵막을 통하여 핵산을 전이시키기 위한 세포내 수송시스템의 용도
US8216843B2 (en) Artificially synthesized peptide
WO2023286766A1 (ja) 抗体と遺伝子に結合能を有するポリペプチド
Khoramgah et al. Transfection of PC12 cell line by pEGFPNI-NT4 and protein expression analysis
Renigunta Development of a DNA transfer technique for human lung cells with synthetic peptide Tat-RGD and its application for regulatory and functional analysis of RELMβ [RELM-beta]
Todorova Methods of protein delivery into mammalian cells for gene therapy and genetic studies
Goparaju Evaluation of cationic peptide-plasmid DNA complexes for gene delivery
KR20050108529A (ko) 단백질 도입부위 및 막활성화 부위가 함유된 새로운 합성펩타이드 및 이를 이용한 유전자 전달 방법

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)